Atlas Trials

Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid

Clinical trial NCT01906671 · UNKNOWN

Trial details

NCT number
NCT01906671
Sponsor
Kjeld Schmiegelow
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia6-mercaptopurine Therapy
Start date
2013-06-01
Primary completion
2018-09-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.